WORLD PEPTIDEFOUNDATION
← Master Registry

Published peptide research references

Insulin efsitora alfa

Governed registry record

4 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.

Approved source records

  1. Evaluating once-weekly insulin efsitora alfa for adults with type 2 diabetes.

    DOI: 10.1080/14656566.2026.2667324

    Source identity and connection checked by Codex (AI).

  2. Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 1 diabetes (QWINT-5): a phase 3 randomised non-inferiority trial.

    DOI: 10.1016/s0140-6736(24)01804-x

    Source identity and connection checked by Codex (AI).

  3. Optimal Use of Once-Weekly Basal Insulin Efsitora Alfa in Type 1 and Type 2 Diabetes: A Systematic Review and Meta-Analysis.

    DOI: 10.1016/j.eprac.2024.12.013

    Source identity and connection checked by Codex (AI).

  4. The Basis for Weekly Insulin Therapy: Evolving Evidence With Insulin Icodec and Insulin Efsitora Alfa.

    DOI: 10.1210/endrev/bnad037

    Source identity and connection checked by Codex (AI).

Legacy research context

Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.

Researchers represented

  • Rosenstock J
  • Juneja R
  • Beals JM
  • Moyers JS
  • Ilag L
  • McCrimmon RJ
  • Bergenstal RM
  • Weinstock RS
  • Mathieu C
  • Onishi Y
  • Vijayanagaram V
  • Katz ML
  • Carr MC
  • Chang AM
  • Ramachandran A
  • Batra J
  • Desouza C
  • Dutta D
  • Nagendra L
  • Kumar M
  • Kamrul-Hasan ABM
  • Bhattacharya S